• Latest Posts

Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing

Sponsored by 26 Oct 2021

Plasmids: How to Solve a Bottleneck in Scalable Gene Therapy Manufacturing?

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

Sofinnova Taps into Italian Gene Therapy with Three Seed Financings

The Top European Biotech Funding Rounds in June

Delayed IPOs and Market Drops Batter Biotech Stocks

ADVERTISEMENT

Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology

In Depth 10 Mar 2021

Can Gene Therapy Cure Blindness?

In Depth 8 Feb 2021

How Next-Generation Gene Therapy Tackles Complex Diseases

A Year to Remember: The Biggest European Biotech News in 2020

In Depth 21 Dec 2020

Enemy or Valuable Ally? How Biotech Uses Viruses for Good

ADVERTISEMENT